Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Overall Study	STARTED	QGE031 24 mg s.c. q4w	43
Overall Study	STARTED	QGE031 72 mg s.c. q4w	84
Overall Study	STARTED	QGE031 240 mg s.c. q4w	85
Overall Study	STARTED	Omalizumab 300 mg s.c. q4w	85
Overall Study	STARTED	Placebo s.c. q4w	43
Overall Study	STARTED	QGE031 120 mg s.c. s.d.	42
Overall Study	COMPLETED	QGE031 24 mg s.c. q4w	40
Overall Study	COMPLETED	QGE031 72 mg s.c. q4w	77
Overall Study	COMPLETED	QGE031 240 mg s.c. q4w	73
Overall Study	COMPLETED	Omalizumab 300 mg s.c. q4w	72
Overall Study	COMPLETED	Placebo s.c. q4w	39
Overall Study	COMPLETED	QGE031 120 mg s.c. s.d.	37
Overall Study	NOT COMPLETED	QGE031 24 mg s.c. q4w	3
Overall Study	NOT COMPLETED	QGE031 72 mg s.c. q4w	7
Overall Study	NOT COMPLETED	QGE031 240 mg s.c. q4w	12
Overall Study	NOT COMPLETED	Omalizumab 300 mg s.c. q4w	13
Overall Study	NOT COMPLETED	Placebo s.c. q4w	4
Overall Study	NOT COMPLETED	QGE031 120 mg s.c. s.d.	5

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02477332/flow